We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » US FDA Looks to Europe for Ideas to Improve Its 510(k) Process
US FDA Looks to Europe for Ideas to Improve Its 510(k) Process
November 13, 2009
The U.S. Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) may incorporate aspects of Europe’s CE Marking
approval rules in its 510(k) clearance process, FDA Principal Deputy Commissioner Joshua Sharfstein says.
To View This Article:
Login
Subscribe To International Medical Device Regulatory Monitor